CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 57 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,111,623 | +73.8% | 4,845,717 | +5.3% | 0.00% | +100.0% |
| Q2 2023 | $82,900,758 | +30.5% | 4,600,486 | +16.3% | 0.00% | 0.0% |
| Q1 2023 | $63,539,110 | -11.4% | 3,956,358 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $71,690,049 | -2.7% | 3,917,489 | +4.4% | 0.00% | -33.3% |
| Q3 2022 | $73,688,000 | +4.3% | 3,752,022 | -1.0% | 0.00% | +50.0% |
| Q2 2022 | $70,675,000 | -2.3% | 3,789,483 | +14.9% | 0.00% | 0.0% |
| Q1 2022 | $72,365,000 | -22.3% | 3,296,780 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $93,077,000 | +69.0% | 3,276,170 | +25.2% | 0.00% | 0.0% |
| Q3 2021 | $55,084,000 | +12.7% | 2,616,839 | +0.9% | 0.00% | +100.0% |
| Q2 2021 | $48,885,000 | +47.7% | 2,593,386 | +19.7% | 0.00% | 0.0% |
| Q1 2021 | $33,105,000 | +11.0% | 2,166,508 | +2.5% | 0.00% | 0.0% |
| Q4 2020 | $29,816,000 | +5.8% | 2,113,195 | +17.5% | 0.00% | 0.0% |
| Q3 2020 | $28,186,000 | -9.0% | 1,798,698 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $30,973,000 | +191.7% | 1,767,869 | +144.8% | 0.00% | 0.0% |
| Q1 2020 | $10,617,000 | -42.2% | 722,303 | -1.3% | 0.00% | 0.0% |
| Q4 2019 | $18,367,000 | +26.7% | 732,055 | -24.1% | 0.00% | 0.0% |
| Q3 2019 | $14,498,000 | -37.8% | 964,002 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $23,312,000 | +31.6% | 932,424 | +19.9% | 0.00% | 0.0% |
| Q1 2019 | $17,708,000 | -14.8% | 777,974 | +12.2% | 0.00% | 0.0% |
| Q4 2018 | $20,789,000 | +73.1% | 693,172 | +65.3% | 0.00% | 0.0% |
| Q3 2018 | $12,013,000 | – | 419,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |